Effect of diphenylhydantoin therapy on folate metabolism of mentally retarded epileptics.
D000293:Adolescent; D000328:Adult; D000927:Anticonvulsants / Q000627:therapeutic use; D001391:Azo Compounds / Q000652:urine; D002648:Child; D004827:Epilepsy / Q000097:blood / Q000150:complications* / Q000188:drug therapy; D005365:FIGLU Test; D005260:Female; D005492:Folic Acid / Q000097:blood*; D005977:Glutarates / Q000652:urine; D006639:Histidine / Q000097:blood; D006801:Humans; D008607:Intellectual Disability / Q000097:blood / Q000150:complications / Q000188:drug therapy* / Q000652:urine; D008297:Male; D009504:Neutrophils; D010672:Phenytoin / Q000494:pharmacology / Q000627:therapeutic use*; D014805:Vitamin B 12 / Q000097:blood
D000927:Anticonvulsants; D001391:Azo Compounds; D005977:Glutarates; D006639:Histidine; D010672:Phenytoin; D005492:Folic Acid; D014805:Vitamin B 12